Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

3:00 PM - 3:10 PM PT

337 - Independent External Validation of Radiation-Induced Esophagitis Prediction during Chemoradiation Therapy for NSCLC Using RTOG 0617 Trial Data
Speaker: Cella, Laura, PhD - National Research Council (IBB), Napoli, Campania
3:00 PM - 3:10 PM PT

LBA 12 - Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Inoperable Locally Advanced Breast Cancer: A Phase 2 Randomized Trial (NEOTRAC)
Speaker: Iyer, Priya, MD, MBBS - Cancer Institute (WIA), CHENNAI, Tamil Nadu
3:10 PM - 3:20 PM PT

333 - Updated Results of RESTART Protocol (<em>R</em>adioth<em>E</em>rapy bridging and con<em>S</em>olida<em>T</em>ion for C<em>AR-T</em>) in Large B-cell Lymphoma
Speaker: Mikhaeel, George, MD, MBBS - Guy's and St. Thomas' NHS Foundation Trust, London, London
3:10 PM - 3:20 PM PT

338 - Interpretable Deep Learning Predicts Metastasis-Free Survival (MFS) from Conventional Imaging for Oligometastatic Castration-Sensitive Prostate Cancer (omCSPC) Using Multi-Modality PSMA PET and CT Imaging
Speaker: Cao, Yufeng, PhD - University of Maryland Central Maryland Radiation Oncology, Columbia, MD
3:10 PM - 3:20 PM PT

LBA 13 - Baseline and Time-Dependent Predictors of Cognitive Decline for Brain Metastasis Patients Treated with Radiotherapy- A Secondary Analysis of the ATHENA Trial
Speaker: Perlow, Haley, MD - Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH
3:20 PM - 3:30 PM PT

339 - 3D Topological Analysis for Assessing Therapeutic Responses to Radiation and Chemotherapy with and without Anti-CD40 Immunotherapy in Local Advanced Rectal Cancer
Speaker: Peng, Hao, PhD - UT Southwestern Medical Center, Dallas, TX
3:20 PM - 3:30 PM PT

LBA 14 - Neoadjuvant and Adjuvant Pembrolizumab (Pembro) Plus Standard of Care (SOC) in Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA HNSCC): Postoperative Risk Subgroup Analysis of KEYNOTE-689
Speaker: Lee, Nancy, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York, NY
3:30 PM - 3:40 PM PT

340 - Radiotherapy-Induced Acute Lymphopenia for Low and Intermediate Risk Prostate Cancer
Speaker: Moteabbed, Maryam, PhD - Massachusetts General Hospital, Boston, MA
3:30 PM - 3:40 PM PT

LBA 15 - Signal-Seeking P2R Trial of Proton or IMRT Dose Intensification in GBM: NRG-BN001
Speaker: Mehta, Minesh, MD, MB, ChB, FASTRO - Miami Cancer Institute- Baptist Health South Florida, Miami, FL
4:00 PM - 4:10 PM PT

341 - Survival Outcomes of Induction Immunotherapy Combined with Platinum-Based Doublet Chemotherapy Followed by Immunotherapy and Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer: A Phase II Clinical Trial
Speaker: Yuan, Yidi, MD - Peking University Cancer Hospital and Institute, Beijing, Beijing
4:00 PM - 4:10 PM PT

346 - Differential Survival Benefits of PORT in AJCC-9th /IASLC-Defined N2 NSCLC Substages: A Multicenter Real-World Study
Speaker: Bao, Yongxing, MD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC, Beijing, Beijing
4:00 PM - 5:00 PM PT

Gyn 4: GYN Clinical Trials - Challenging the paradigm in gynecologic cancers
Speaker: Fabian, Denise, MD - University of Kentucky, Lexington, KY